Accounts Receivable, Net

3 Months Ended

Mar. 31, 2022

Receivables [Abstract]

Accounts Receivable, Net

Note 3 – Accounts Receivable, Net

The following amounts were included within Accounts receivable, net:

(In millions)	March 31, 2022		December 31, 2021
Noninsurance customer receivables	$	7,200	$	6,274
Pharmaceutical manufacturers receivables	5,805		5,463
Insurance customer receivables	2,647		2,932
Other receivables	399		456
Total	16,051		15,125
Accounts receivable, net classified as Assets of businesses held for sale	(48)		(54)
Accounts receivable, net per Consolidated Balance Sheets	$	16,003	$	15,071

These receivables are reported net of our allowances of $1.5 billion as of March 31, 2022 and $1.4 billion as of December 31, 2021. These allowances include contractual allowances for certain rebates receivable with pharmaceutical manufacturers and certain receivables from third-party payors, discounts and claims adjustments issued to customers in the form of client credits, an allowance for current expected credit losses and other non-credit adjustments.The Company's allowance for current expected credit losses was $65 million as of March 31, 2022 and $60 million as of December 31, 2021.